Therapeutic area

Infections and infestations – page 51

686 clinical trials
263 recruiting
279 conditions
27 countries

Clinical trials in Infections and infestations

686 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

686 clinical trials

HIV infection

Not recruiting

Study on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns

Registered drugNo placebo

Study on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Bictegravir
Sponsor:Fundacion Seimc Gesida

Contact Research Centre

Pneumonia

Not recruiting

Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Registered drug

Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Amikacin
Sponsor:Insmed Inc.

Contact Research Centre

COVID-19

Not recruiting

Study on the Safety and Effectiveness of Nirmatrelvir and Ritonavir for Nonhospitalized Children with COVID-19 at Risk of Severe Illness

InvestigationalNo placebo

Study on the Safety and Effectiveness of Nirmatrelvir and Ritonavir for Nonhospitalized Children with COVID-19 at Risk of Severe Illness

InvestigationalNo placebo

Bulgaria

Participants:0–17 years
Substances:Nirmatrelvir
Sponsor:Pfizer Inc.

Contact Research Centre

Bacterial infection

Not recruiting

Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

Registered drugNo placebo

Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ertapenem Sodium
Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Contact Research Centre

Post-acute COVID-19 syndrome

Not recruiting

Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Investigational

Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Vidofludimus Calcium
Sponsor:Goethe University Frankfurt

Contact Research Centre

Sepsis+1

Not recruiting

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Registered drug

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Terlipressin Acetate
Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Contact Research Centre

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Registered drugNo placebo

France

Participants:18–64 years
Substances:AB-729
Sponsor:Arbutus Biopharma Inc.

Contact Research Centre

Escherichia urinary tract infection

Not recruiting

Study of ExPEC9V vaccine for preventing invasive E.

Investigational

Study of ExPEC9V vaccine for preventing invasive E.

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:ECOO15
Sponsor:Janssen Vaccines & Prevention B.V.

Contact Research Centre

Herpes simplex

Not recruiting

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Registered drugNo placebo

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anhydrous Cidofovir
Sponsor:AiCuris Anti-infective Cures AG

Contact Research Centre

Systemic candida

Not recruiting

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Registered drug

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Anidulafungin
Sponsor:Scynexis Inc.

Contact Research Centre

Vaginal infection

Not recruiting

Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

Investigational

Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

Investigational

France

Participants:18–64 years
Substances:Lactobacillus rhamnosus, strain LCR35, live
Sponsor:Nexbiome Therapeutics

Contact Research Centre

COVID-19

Not recruiting

Study of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway

Registered drug

Study of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway

Registered drug

Norway

Participants:18–64 years
Substances:Nirmatrelvir
Sponsor:Helse Bergen HF

Contact Research Centre

Substances studied in this area

The therapies tested most often in Infections and infestations trials.

Sodium Chloride52 clinical trials Amoxicillin35 clinical trials Emtricitabine33 clinical trials Tenofovir Alafenamide33 clinical trials Linezolid32 clinical trials Clavulanic Acid28 clinical trials Rifampicin25 clinical trials Sulfamethoxazole25 clinical trials Trimethoprim25 clinical trials

Infections and infestations – page 51

Conditions in this area

Clinical trials in Infections and infestations

686 clinical trials

HIV infection

Study on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns

Pneumonia

Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

COVID-19

Study on the Safety and Effectiveness of Nirmatrelvir and Ritonavir for Nonhospitalized Children with COVID-19 at Risk of Severe Illness

Bacterial infection

Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

Post-acute COVID-19 syndrome

Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Sepsis+1

Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

Escherichia urinary tract infection

Study of ExPEC9V vaccine for preventing invasive E.

Herpes simplex

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Systemic candida

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Vaginal infection

Study on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections

COVID-19

Study of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.